Background: Monocyte chemoattractant protein-1 (MCP-1) is expressed in adipose tissue, macrophages, endothelial cells, and osteoblasts by parathyroid hormone administration. Circulating MCP-1 levels are positively correlated with the degree of obesity. However, whether circulating MCP-1 affects bone metabolism is unclear. Therefore, in this study, the association between circulating MCP-1 levels and lumbar bone mineral density (BMD) based on menopausal status was assessed. Methods: We recruited 109 premenopausal and 46 postmenopausal Korean women and examined the association between circulating MCP-1 concentrations and various parameters including lumbar BMD based on menopausal status. Results: A significant increase in body weight, abdominal circumference, body mass index, and MCP-1 levels (from 245.9±73.5 to 336.5±101.7 pg/mL) and significant decrease (from 0.992±0.114 to 0.772±0.113 g/cm 2 ) in lumbar BMD were observed after menopause. However, circulating MCP-1 levels were not correlated with any parameters including lumbar BMD in premenopausal or postmenopausal women. Conclusion: Circulating MCP-1 levels were not correlated with lumbar BMD regardless of menopausal status.
INTRODUCTION
Chemotactic cytokine, monocyte chemoattractant protein-1 (MCP-1)/C-C motif chemokine ligand 2 is a major ligand for C-C motif chemokine receptor 2.
1-3 MCP-1 and its receptor, C-C motif chemokine receptor 2, are important for monocyte and macrophage recruitment in inflammation. [3] [4] [5] MCP-1 is overexpressed in the adipose tissue of obese rodents. 4, 6, 7 In various ethnic populations [8] [9] [10] [11] [12] [13] , MCP-1 expression is higher in obese individuals and in visceral adipose tissue and positively associated with obesity or insulin resistance. MCP-1 is expressed in various types of cells such as vascular endothelium, fibroblasts, smooth muscle cells, and monocytic cells. 14 In addition, osteoblast lineage cells in the bone marrow were shown to express increased MCP-1 after parathyroid hormone (PTH) administration. 14 Tamasi et al. 14 showed that MCP-1 in bone is a core mediator for the anabolic effect of human PTH
(1-34). Therefore, it is speculated that circulating MCP-1 levels (not MCP-1 secreted by bone cells) are possibly associated with bone metabolism. Sukumar et al. 15 demonstrated serum MCP-1 levels were positively associated with bone turnover markers in lean women but not obese women, and were weakly associated with femoral neck and hip bone mineral density (BMD) in both types of women (P < 0.09). However, the authors did not analyze the study results based on menopausal status or use lumbar BMD.
In our previous study 16 , circulating MCP-1 concentrations were associated with menopausal status, irrespective of obesity. Therefore, in the present study, we assessed the association between circulating MCP-1 levels and lumbar BMD based on menopausal status in Korean women.
METHODS
The subjects in the present study were recruited during our previous study 16 at the Eulji University Hospital in Korea from January 
RESULTS
The mean age of premenopausal women was 39 years and of postmenopausal women 60 years. A significant increase in body weight (55.5 ± 7.0 vs. 58.9 ± 9.5 kg), abdominal circumference ) were observed after menopause, as shown in Table 1 . However, circulating MCP-1 levels were not correlated with any anthropometric data, blood parameters, or lumbar BMD in premenopausal or postmenopausal women, as shown in Table 2 . Second, we used only lumbar BMD without femoral BMD in the analysis. Third, the number of subjects in this study was small.
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